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treatments were available. Postoperative follow-up
angiography showed a high rate of graft failure, and the
use of this conduit was completely abandoned after
1976.2,3
Several cases in which a patent RA graft was seen
after 15 years led us to reinvestigate the use of this con-
duit for coronary revascularization,4 and in 1989 we ini-
tiated a new study including 910 patients to date. Some
modifications of the original technique were introduced
with respect to the preparation of the RA and the
adjunctive use of an antispasmodic drug. Early clinical
and angiographic results were excellent, with a patency
rate of 92% at 1 year.4 Similar results were obtained by
other authors.5-9
Nevertheless, the exact outcome of the RA graft in the
long term remains unknown. The aim of this study was
T he use of the radial artery (RA) for coronary arterybypass grafting was first introduced by Carpentier et
al1 in 1971. At that time the study was conducted with
a limited number of patients and no antispasmodic
Objective: The aim of this study was to assess the long-term results of use
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to report the clinical and angiographic results of the RA
graft after a 5-year period.
Methods
Between July 1989 and July 1997, 910 patients underwent
coronary artery bypass grafting with the RA. To obtain the
late clinical status of these patients, the cases of the first 102
consecutive patients operated on, between July 1989 and July
1993, were reviewed. Complete follow-up data were ob-
tained. At the termination of the study period, the mean age
was 67 ± 9 years, ranging from 51 to 83 years. Among the
102 patients, the following risk factors were noted: systemic
hypertension (52%), diabetes mellitus (30%), and hyperlip-
idemia (59%). Coronary revascularization with the RA was a
reoperative procedure in 9% of the cases.
The surgical technique has been previously described.4,10 An
Allen test was routinely performed, and in the case of a posi-
tive result a Doppler study of the forearm was carried out to
verify the patency of the ulnar artery. In the presence of a nor-
mal pulsatile flow of the ulnar artery, the RA was harvested.
Immediately before implantation, the RA conduit was
catheterized with a 20-gauge catheter and gentle hydrostatic
dilatation of the graft was accomplished with a mixture of
blood and papaverin to completely release the spasm. The site
of proximal anastomosis was the ascending aorta (on a 4-mm
hole) in 98% of cases, the left internal thoracic artery (ITA)
in 1.2%, and a coronary artery proximal to the stenosis (coro-
nary-coronary bypass) in 0.8%.
A calcium-channel inhibitor (diltiazem, 0.1 mg/kg/h) was
administered intravenously in the intensive care unit. It was
then prescribed orally (250 mg/d) in conjunction with low-
dose aspirin (100 mg/d).
The average number of grafts was 2.79 ± 0.8 per patient (1-
5 grafts per patient). A total of 122 RA grafts were construct-
ed. In addition the following conduits were used for bypass:
97 pedicled left ITA grafts, 31 pedicled right ITA grafts, 10
free ITA grafts, and 23 saphenous vein grafts.
The implantation sites of both the RA grafts and the left
ITA grafts are shown on Table I. An associated valve proce-
dure was performed in 9 cases (aortic valve replacement, n =
6; mitral valve repair, n = 3).
At the completion of the follow-up, all patients underwent
an interview and a physical examination. In addition, stress
test electrocardiographic (ECG) examination was performed
in all patients who had no contraindications.
Angiographic methods. The first 75 patients systemati-
cally underwent angiography immediately after the operation
(2 weeks). In addition the first 61 patients were again
catheterized at 1 year.
Late follow-up angiography was proposed for all surviving
patients among the first 102 who underwent coronary artery
bypass grafting with the RA. Indication for late angiography
was the patient’s acceptance only. Fifty follow-up
angiograms were successively performed from 4 to 7 years
after the operation (mean 5.6 ± 1.10 years). All patients with
symptoms of angina or infarction underwent follow-up stud-
ies (n = 14). In addition, 36 symptom-free patients agreed to
undergo the examination.
Statistical analysis. Clinical data (mortality rate and recur-
rence rate of angina) were analyzed in a time-related format
by the life table method. The number of patients at risk was
indicated on the curve for each interval, with error bars for
95% confidence intervals (Figs 1 and 2). Results were reported
as mean ± standard deviation. Patency rates between groups
were compared with the c 2 test.
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Table I. Implantation sites of grafts
Coronary artery RA (%) Left ITA (%)
LAD 4 94
Diagonal 16 2
Circumflex 51 4
Right 29 0
Fig 1. Actuarial survival rates after coronary artery bypass grafting with the RA.
Results
Among the 910 patients operated on during this time
frame, no patients had contraindications to the use of the
RA on the basis of blood supply study of the forearm. A
positive Allen test result was noted in 36 patients (3.9%).
Verification of the ulnar artery by Doppler study showed
a normal flow in all cases, and RA removal was carried
out. However, intraoperative inspection of the RA
revealed that this vessel was unsuitable as a graft in 18
cases for the following reasons: calcifications related to
diabetes (n = 9), calcifications related to multifocal athero-
ma (n = 5), and chronic dissection related to catheteriza-
tion of the RA during a previous operation (n = 4). The
frequency of unusable graft findings was thus 2.0%.
There were no ischemic episodes of the hand after
RA removal. No morbidity was observed at the level of
the forearm. In 3 cases chronic dysesthesia of the
thumb was seen, but with no functional incapacity.
Clinical results. Nine patients died during the period
of follow-up, 4 of cardiovascular disorders and 5 of
noncardiac causes. The causes of death are listed in
Table II. The actuarial survival curve, shown in Fig 1,
yielded a 91.6% ± 3.11% survival rate at 5 years. The
93 survivors were all reviewed after a mean follow-up
of 5.27 ± 1.30 years (4-7 years after the operation).
At the time of follow-up the following medications
had been prescribed by the cardiologists: calcium-
channel inhibitors (59%), b -blockers (30%), and
nitrates (46%). In addition, 77% of the patients were
receiving aspirin and 15% were receiving warfarin.
Thirteen patients (14%) had occasional stable angina.
One patient had an acute infarction caused by RA graft
closure. The actuarial curve of freedom from angina,
shown in Fig 2, yielded 88.7% ± 3.43% of patients free
from angina at 5 years.
Symptoms of congestive heart failure were noted in 6
cases. Four patients underwent percutaneous translu-
minal angioplasty a mean of 3.2 years after the opera-
tion, and 1 patient underwent reoperation for aortic
valve stenosis at 3 years (with all grafts patent). There
was no reoperative coronary artery bypass grafting.
Fifty-one patients could undergo a stress test ECG
examination. Contraindications for this examination
were as follows: ventricular arrhythmias (n = 5), severe
arthrosis (n = 5), age >75 years (n = 12), angina pec-
toris or recent infarction (n = 14), and arteritis of the
lower limbs (n = 6). The stress test was realized at 84%
± 2% of the theoretic maximal heart rate. The power
developed during exercise was 118 ± 6 W.
Thirty-seven patients (73%) had a negative stress test
result. The test yielded electrically positive results with
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Fig 2. Actuarial freedom from angina after coronary artery bypass grafting with the RA.
Table II. Causes of death
Cause of death No.
Cardiac
Congestive heart failure 2
Aortic dissection 1
Arteritis 1
Noncardiac
Cerebral hemorrhage 1
Diabetic coma 1
Peritonitis 1
Pancreatic cancer 1
Suicide 1
ST segment changes in 11 cases (21%) and clinically
positive results with the onset of angina in 3 cases
(6%).
Angiographic results
Early results. Early postoperative and 1-year angio-
graphic results of this series have been previously pub-
lished.4,10 Seventy-five RA grafts were opacified in the
early postoperative period (2 weeks): 1 graft was occlud-
ed, 4 grafts showed a narrowing unrelated to the anasto-
motic line and most probably caused by spasm, and 70
RA grafts showed an excellent result. At 1 year, follow-
up angiograms of 61 RA grafts were obtained and
showed the following: 4 occluded RA grafts, 1 string
sign, 1 low-grade stenosis, and 55 excellent results. The
patency rates of the RA grafts were thus 99% in the post-
operative period and 92% at 1 year, respectively.
Five-year results. Fifty patients agreed to undergo
late angiography from 4 to 7 years after the operation.
Sixty-four RA grafts were opacified: 10 grafts were
occluded, 1 graft had a string sign, and 53 grafts were
perfectly functioning with no stenosis (Figs 3-6). The
patency rate of these RA grafts thus was 83%.
With the aim of clarifying the causes of RA graft fail-
ure (n = 11), careful analyses of all preoperative and
postoperative angiograms were carried out. A hemody-
namic factor that could have promoted graft closure
was found in 8 cases. In 5 of these cases the absence of
significant stenosis on the native coronary bed was
probably responsible for a competitive flow, and in 3
cases the distal runoff was poor or displayed a signifi-
cant stenosis. No hemodynamic explanation could be
found in 3 cases.
In the meantime, angiograms of 47 pedicled left ITA
grafts were obtained. Three grafts were occluded and 1
showed a high grade stenosis. The patency rate of the
left ITA grafts thus was 91% at 5 years (vs 83% for the
RA, P = .19; Fig 7).
During the follow-up period, percutaneous coronary
angioplasty was performed in 4 patients at the follow-
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Fig 3. Sequential RA graft on the circumflex system at 5
years.
Fig 4. RA graft to diagonal artery at 7 years.
Fig 5. A, Prolonged stenosis of the midportion of RA conduit
(arrow) at 3 years. B, Almost complete release of the steno-
sis after percutaneous transluminal coronary angioplasty.
A
B
ing sites: RA graft (n = 1, Fig 5), native coronary artery
supplied by an occluded graft (n = 2), and nongrafted
coronary artery (n = 1). In patients with recurrence of
angina, follow-up angiography at 5 years showed graft
failure in 9 cases (including 5 RA grafts) and progres-
sion of coronary disease in the native vessels in 5 oth-
ers, whose grafts were all patent. Among the 50
patients undergoing late angiography, 27 were receiv-
ing calcium-channel inhibitors and 23 had discontinued
this treatment for at least 6 months. The numbers of
occluded RA grafts in these 2 groups were 8 and 4,
respectively (c 2 test P = .31).
Discussion
The clinical follow-up of patients operated on in this
series confirmed the safety of RA removal. There was
no significant morbidity at the site of RA graft harvest-
ing. On rare occasions a mild dysesthesia of the thumb
was observed; the mechanism of this was probably a
traumatic injury to a superficial branch of the radial
nerve. This complication is similar to the lesions of the
saphenous nerve responsible for a dysesthesia of the
superior aspect of the foot after removal of the saphe-
nous vein in the leg. In no instance did this symptom
lead to functional incapacity.
The skin incision usually healed rapidly. The occur-
rence of local infection was an exception, unlike in the
case of the incision used for harvesting the saphenous
vein at the thigh.
The quality of the RA allowed its use as a coronary
artery bypass graft in almost all cases. Nevertheless,
the existence of calcifications (from diabetes or multi-
focal atheroma) or traumatic lesions (from coronary
angiography through the RA or placement of invasive
blood pressure catheter) precluded the use of an RA
graft in 2% of the cases. Thus particular attention must
be taken when harvesting the RA in coronary reopera-
tions because chronic dissection of this vessel resulting
from pressure monitoring can be encountered. As a
rule, it seems preferable to use the proximal segment of
the RA in these patients in whom dissections occurred
or with calcifications.
In this series no patient had contraindications for the
use of an RA graft according to the result of the Allen
test or the Doppler study of the ulnar flow. No signs of
hand ischemia occurred, even in patients whose jobs
required an extensive use of the arm (a house painter
and a violinist).
The survival rates in this series were similar to those
in various reports from the literature with other types of
conduits.11 The actuarial rate of freedom from angina
was 86% at 5 years (Figs 1 and 2).
ECG stress testing is considered a gold standard for
detecting the existence of silent ischemia in coronary
artery disease. In this series ECG stress testing could
not be performed in all cases because of frequent con-
traindications related to the patient’s age or associated
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Fig 6. Sequential and Y RA grafts on 2 diagonal branches at
6 years.
Fig 7. Five-year angiographic results of RA versus left ITA
grafts. The difference in patency between these 2 arterial
grafts (83% vs 91%) could be related to the graft implanta-
tion sites.
disease. During the test heart rate frequently remained
below the theoretic calculated level because a third of
the patients were still receiving b -blocker agents, which
restricted their response capacity to exercise. However,
the power developed during exercise was satisfactory
and usually exceeded 110 W. It is not surprising to find
out that the ECG stress test results were positive in 25%
of the cases, because these patients initially had triple-
vessel disease and their coronary disease continued to
progress throughout the 5-year period of follow-up.
Follow-up angiography is the only technique capable
of completely analyzing the characteristics of a con-
duit, with patency being the ultimate criterion of suc-
cess. In this study repeated angiography was performed
to analyze the fate of the RA conduits (Fig 8).
There was a relatively high incidence of spasm of the
RA graft seen on postoperative angiography (Fig 8). It
should be stressed that this was invariably an angio-
graphic finding and that no patients had any clinical or
ECG signs suggesting dysfunction of the RA graft.
These spasms were most probably induced by the
angiographic catheter selectively introduced into the
RA graft. This phenomenon was observed only in the
early postoperative period and was not found during the
later angiography, at 1 year and at 5 years. It thus seems
that the vasoreactivity of the RA is maximal in the days
after the operation.
The RA is a muscular artery that has a media rich in
leiomyocytes.12,13 The contraction of this small-diame-
ter artery produces an extensive reduction in size of the
lumen. The hemodynamic effects of the RA spasm are
probably greater than those of a spasm involving the
ITA, which has a media poor in leiomyocytes,14 or a
saphenous vein, which has a much larger diameter.
Consequently, it seems necessary to obtain an RA graft
that is free of spasm at the time of construction of the
coronary anastomoses.
As a rule, the RA is constricted at the end of the dis-
section. In this series the RA was catheterized and hydro-
static dilation was undertaken at a low pressure with a
mixture of blood and papaverin until total release of the
spasm on the whole length of the graft was obtained.
Histologic studies conducted in our laboratory have
shown that this maneuver is not harmful to the architec-
ture of the arterial wall. Notably, the same technique was
also used before implantation of a venous conduit.
The prescription of calcium-channel inhibitors to
patients receiving ITA grafts is a widespread practice,
although no study has clearly demonstrated the benefi-
cial effects of this drug on graft patency. The same is
true concerning the use of the RA graft, and we used to
prescribe a calcium-channel inhibitor (diltiazem)
administered intravenously in the intensive care unit
and then orally. This attitude seems logical in light of
the spastic characteristics of the RA graft, particularly
in the postoperative period. Late follow-up of our
patients revealed that the cardiologists had not always
followed the initial recommendations concerning the
drug therapy, however, and 5 years after the operation
only 60% of the patients with RA grafts were still
receiving a calcium-channel inhibitor. To our surprise,
there was no difference in patency of the RA graft
according to whether the patient was taking this drug.
The interpretation of angiographic data must take
into consideration the implantation sites of the grafts.
In fact, it has been clearly demonstrated that both the
diameter of the target artery and its location (left ante-
rior descending coronary artery [LAD] vs non-LAD
site) strongly influences the patency of grafts.15,16
At 1 year the patency rate of the RA graft was 92%,
apparently higher than that of vein grafts constructed
under the same conditions (on non-LAD coronary
arteries). Indeed, recent multicenter studies have shown
that the patency rate of vein grafts at 1 year was 80%
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Fig 8. Fate of RA grafts. The relatively high incidence of stenosis on early postoperative (POSTOP) angiography
is due to spasm and is no longer observed at 1 and 5 years.
among grafts that had not been anastomosed to the
LAD.15-17
The higher incidence of early graft failure is unlikely
to be related to histologic changes of the venous wall,
which did not have time to take place in such a short
time frame. Conversely, the superior hemodynamic
characteristics of the RA graft compared with those of
saphenous vein graft could account for the difference in
patency. The RA has a diameter close to that of the
coronary arteries, and the diameter ratio between the
graft and the target vessel never exceeds 2:1. In addi-
tion, this graft is free of valvulae and its caliber is homo-
geneous throughout its whole course, with a slight
decrease in diameter from the proximal to the distal end.
The hemodynamic characteristics of the saphenous vein
are completely different. The diameter of the vein is
invariably larger, frequently leading to a major discrep-
ancy in size with the coronary artery in which the diam-
eter ratio can reach 5:1. Furthermore, the saphenous
vein is rich in valvulae and its diameter is not constant,
with abrupt changes at the level of collateral branches.
The diameter of the vein increases from the proximal to
the distal end. These relatively unfavorable hemody-
namic characteristics probably account for the higher
early occlusion rate of venous grafts when they are
anastomosed to small target vessels.
At 5 years, the difference in patency between RA and
venous graft is further magnified. Except in the case of
1 patient whose RA stenosis was successfully treated
with percutaneous transluminal coronary angioplasty
(Fig 5), no signs of graft disease were noted in this
series. The 5-year patency rate of the RA (83%)
appears to be higher than that of the venous grafts
reported in the literature (55% according to Lytle et
al18). The latter are frequently affected by graft disease,
with progressive intimal hyperplasia responsible for
stenosis and occlusion.18 The arterial ultrastructure of
the RA graft is accustomed to a systemic pressure reg-
imen and, as with the ITA graft, this could account for
the superior late patency of the graft.
In this series the patency rate of the RA graft at 5
years was slightly lower than that of the ITA graft (Fig
7). It should be emphasized that all RA conduits were
constructed on small target vessels, with half of the
radial arteries anastomosed to the circumflex system
and a third to the right coronary artery. Conversely, the
left ITA was almost always anastomosed to the LAD.
Thus the difference in patency between these 2 arterial
grafts could be related to the graft implantation sites.
Interestingly, in a study by Loop et al19 the ITA when
used as a free graft offered the same late patency rate to
that of the RA, with 84% of the free ITA grafts being
patent at 5 years.
To determine the causes of RA graft occlusion, all
preoperative and postoperative angiograms of patients
with graft failure were carefully analyzed. The factors
influencing graft patency were not specific to the RA
and have been well documented for other arterial or
venous conduits, whether used as free or pedicled
grafts. In most cases a hemodynamic factor that could
have promoted graft occlusion was observed. The
absence of significant stenosis of the native coronary
arteries, resulting in competitive flow, was frequently
encountered. Occasionally preoperative angiograms
displayed a poor or multiply stenosed distal runoff.
In conclusion, the RA for coronary bypass grafting
stands the test of time and offers excellent clinical and
angiographic results at 5 years. Routine use of this con-
duit can be recommended. Ultimately, the superiority
of the RA graft with respect to the vein graft will need
to be confirmed by a prospective randomized study
with early and late follow-up angiography.
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Discussion
Dr Hendrick B. Barner (St Louis, Mo). Dr Acar and asso-
ciates are to be complimented for providing us with the only
5-year follow-up of the RA graft, with an impressive 83%
patency rate. Although current enthusiasm for the RA has
emanated from Paris throughout the world, I continue to find
that some surgeons are skeptical and want to know why the
RA is better now than it was before. It is important to address
this concern, which has to do with the evolution of surgical
technique and basic science.
We treated all conduits badly in the early 1970s by inflicting
mechanical trauma during harvesting and chemical and physi-
cal injury as we attempted to overcome harvest spasm. As a
consequence, the endothelium was damaged or destroyed.
It was not until Furchgott and Zawadzki reported in 1980
the existence of endothelially derived relaxing factor that we
realized that the endothelium was more than a passive barrier.
Subsequently, we learned that the endothelium continuously
elaborates nitric oxide at a basal level and that as flow
increases the associated shear stress stimulates greater pro-
duction of nitric oxide.
It is true that the RA has more smooth muscle in its wall
than do the other arterial conduits and that harvest spasm is
therefore more intense and resistant to treatment. Although
we have the pharmacologic means to overcome harvest
spasm, the essence of maintaining patency in an arterial con-
duit is functional preservation of the endothelium so that the
normal physiologic interplay of vasoactive substances is
allowed to prevail and result in a functioning conduit.
Without the presence of endothelially derived nitric oxide,
prostacyclin, hyperpolarizing factor, and perhaps other vaso-
dilators, the natural tendency is for all conduits to narrow and
even close because of the presence of vasoconstrictor media-
tors and the nature of vascular smooth muscle to contract.
Additionally, nitric oxide inhibits platelet aggregation and
adherence, leukocyte adherence, and scavenging of superox-
ide radicals.
I therefore believe that it is this evolution in science and
surgery that has allowed us to arrive at this milestone in res-
urrection of a fallen surgical technique by a group that had
the wisdom to recognize the importance of clinical observa-
tions and new knowledge and had the insight to try it again.
Dr Acar, is the small number of conduits per patient relat-
ed to the fact that not all patients had triple-vessel disease? It
appears that you have not used sequential anastomoses or
conduit-to-conduit anastomoses in any great numbers. Do
you believe that these are not appropriate techniques, or that
they should only be used in special circumstances? What is
your current practice with respect to short- and long-term
calcium-channel blocker therapy? Have you correlated RA
patency with long-term calcium-channel blocker use?
Dr Richard F. Brodman (Bronx, NY). Following the lead
of Dr Acar and associates, I have been using the RA routinely.
Since November 1993 I have performed 369 consecutive
coronary artery bypass graft procedures. Three hundred
sixty-eight RAs were harvested in 266 patients. Ninety per-
cent of the bypass grafts in the 266 patients were arterial, and
60% of these were performed with the RA graft. The average
number of grafts per patient was 3.3.
The complications of RA harvest have been nearly absent,
and there have been no instances of hand ischemia. Our fol-
low-up extends to 31⁄2 years and is remarkably similar to that
of Dr Acar and associates, although not as long. At 1, 2, and 3
years’ follow-up—these data were accumulated prospectively
by my nurse practitioner, Rosemary Frame, by direct commu-
nication with the patient on the anniversary of that patient’s
operation—85% to 88% of the patients had no symptoms and
42% to 44% were still taking calcium-channel blockers.
I have the same initial question that Dr Barner had with
respect to calcium-channel blockers. Although you have only
performed recatheterization in a small number of cases, are
there any differences between those patients who were taking
calcium-channel blockers and those who were not?
In Dr Coltharp’s discussion of your RA presentation at The
Society for Thoracic Surgeons meeting in 1992, he stated that
their angiographic patency rates at 5 years and 10 years were
similar. Although the patency rates of 65% and then 60%
reported by Coltharp are lower than the excellent patency rate
at 5 years that you reported today, do you think that the 5-year
patency rate of RA grafts will predict the 10-year patency
rate? Are there any subtle angiographic findings in your 5-
year postoperative catheterizations that worry you?
Dr Francisco Diniz Affonso da Costa (Curitiba, Brazil). In
Curitiba, Brazil, we have performed 218 myocardial revascu-
larization procedures with the RA during the last 3 years.
Among the first 100 cases we performed angiography before
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hospital discharge in 81, with an early patency rate of 96%.
Twenty-six patients, including 3 patients with symptoms,
underwent a late angiographic follow-up study between 6 and
33 months, with only 1 occlusion found. Five of these patients
were studied after 12 months of follow-up. Although our proto-
col recommends the use of calcium channel blockers after the
operation, 30% of them had discontinued the use of this med-
ication by the time of late restudy, with no apparent adverse
effects. It is our impression that the vasomotor reactivity of the
RA, as demonstrated by some localized catheter-induced spasm
during the time of angiography, diminishes with time. We have
not observed this phenomenon in the late studies.
I have a question for Dr Acar. Although the use of a com-
posite RA graft from the left ITA, as advocated by others,
gives you some extra length to reach the extremely distal
marginal branches, it seems to me that there is no advantage
in terms of patency rate with this maneuver. What are your
current thoughts on the site of the proximal anastomosis for
the RA graft?
Dr Nitu Vasant Mandke (Mumbai, India). During the past
30 months we have performed more than 1000 RA grafts in all
combinations, as individual single grafts, sequential grafts, as
Y or T grafts, from ITAs. I do not want to present all my data,
but we have encountered some problems and gone around
them, and I just wanted to get some information from you.
We usually find that the RA diameter is a little bit smaller
in Indian patients. Do you find any statistical relationship
between the patency rate of the smaller diameter of the RA
and the long-term patency? Also, in some patients we do get
a small pedicle. In some patients the area surrounding the RA
(available to create the pedicle) is not really big.
One of our patients had a sequential RA graft to the poste-
rior descending artery and posterolateral branch and could
not be weaned from cardiopulmonary bypass. When we rec-
ognized that this was a case of RA spasm, we had to put in an
additional saphenous vein graft to the posterior descending
artery and posterolateral branch. The patient could then easily
be weaned from cardiopulmonary bypass. From that time for-
ward, we started injecting a papaverine and diltiazem mixture
into the pedicle or the RA, which eliminated our problems of
RA spasm. Since that time we have had no such difficulties
with RA grafts.
We have found that some patients older than 65 years have
calcifications in the RA that can easily be seen with the naked
eye. Would you discard such RAs, or can one still go ahead
and use them? I ask this question because you reported that
your oldest patient with RA conduit placement was 85 years
old.
Dr Olivier Jegaden (Lyon, France). I want to emphasize 2
points from your results. First, you used the RA to bypass the
left coronary network in 71% of the patients. Second, you
showed that the 5-year patency rate of RA was 5% or 6%
lower than that of the ITA. I have 2 related questions. First,
why did you not use bilateral ITA grafts in your patients?
Second, for which indications do you think that RA graft can
be justified as an alternative to ITA graft?
Dr Acar. Dr Barner, despite the fact that most patients had
triple-vessel disease in this series, the mean number of grafts
per patient was 2.8. It is our policy to construct coronary
bypasses only on satisfactory target vessels whose size equals
or exceeds 1 mm. Consequently, the number of grafts seldom
exceeded 4 per patient. Sequential or Y graft techniques were
used on rare occasions, and we favored the use of 1 graft per
coronary vessel.
An important issue concerns the use of calcium-channel
blockers and its relationships to late patency rate. Although
we did not have enough data in this series to allow sophisti-
cated statistical analysis, we have tried to match the cases of
patients with and without calcium-channel blockers. This
study failed to demonstrate any difference related to the anti-
spasmodic treatment. It is interesting to note that we never
observed any case of spasm when performing follow-up
angiography beyond the first postoperative year. It may well
be that the calcium-channel blocker therapy could safely be
interrupted after this time frame.
Dr Brodman, it seems dangerous to extrapolate the 10-year
results of the RA grafts from this study, which reports results
at 5 years. It is noteworthy that the number of occluded grafts
per year was the highest during the first postoperative year
and decreased during the second year and beyond that time.
The patency rates were 99% at 1 month, 92% at 1 year, and
83% at 5 years. There were no signs of graft disease in any
patients in this series, except in the case of 1 patient who
underwent percutaneous transluminal angioplasty at 3 years.
Dr da Costa mentioned the use of composite arterial grafts.
We believe that the anastomosis of the RA to the ITA can
sometimes be technically difficult, and we are reluctant to
systematically anastomose the RA to the ITA for fear of
impairing the early patency rate of the most important graft,
namely the left ITA to LAD. Therefore in most cases the RA
was directly anastomosed to the ascending aorta. This tech-
nique has remained reproducible and safe.
Dr Mandke raised a question concerning the patency rate of
small RA vessels versus that of larger vessels. A statistical
analysis in this series would require a larger number of
angiograms. However, we believe that the size match between
the graft and the coronary vessel is probably more important
for the patency than is the size of the graft itself. In this series
the size of the RA in our patients was invariably larger than the
size of the coronary vessel. On the other hand, RA with calci-
fications or traumatic lesions should not be used for bypass.
Finally, Dr Jegaden proposed routine use of bilateral ITAs
rather than a combination of the left ITA with the RA, which
has been our choice. Many surgeons are reluctant to use bilat-
eral ITA routinely because of the higher incidence of wound
complications, in particular in elderly patients and those with
diabetes. Although the left ITA has been shown to be an
excellent graft for the LAD, the patency rate of the right ITA
constructed on other target vessels is not as well established.
In our practice the use of bilateral ITAs was restricted to
young patients, younger than 55 years, and it would be used
in a combination with the RA graft.
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